Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05780021

Motivational Support Program in Chronic Low Back Pain After Multidisciplinary Functional Rehabilitation

Chronic low back pain (CLBP) is a major public health problem. Multidisciplinary functional rehabilitation program (FRP), which give patients the skills to better manage pain and return to physical activity, are effective in the short term. In the medium and long term, due to lack of motivation, two thirds of patients stop their physical activity again, causing them to fall back into the vicious circle of pain. Investigators hypothesise that a remote assessment and motivational support program (MSP) based on an application, piloted by a care coordinator, could allow the continued improvement of symptoms and activities observed after the FRP programs, and thus limit the consequences of CLBP for the patient and society. The main objective of this study is to evaluate the effect of the motivational support program EMOTIV, on disability and pain at one year, in chronic low back pain patients who have benefited from a FRP program.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Chronic Low-back Pain

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Multidisciplinary functional rehabilitation program (FRP) have shown their efficacy in disabilitie patient suffering from Chronic low back pain (CLBP). Unfortunately, at medium and long term two thirds of patients stop their physical activity due to lack of motivation. These patients then fall back into their painful vicious circle. Investigators hypothesis that motivational support program (MSP) based on an application, piloted by a care coordinator could increase the motivation to continue physical activity and thus limit the consequences of CLBP for the patient and society. The main objective is to evaluate the impact of a MSP (EMOTIV) on pain and functional abilities assessed according to the COMI scale (Core Outcome Measure Index), 12 months after a FRP in patients with LPBC. This program is compared to usual care as currently done. The secondary criteria concern: physical, neuropsychological and medico-economical criteria. This is a multicentre, cluster randomized trial. All adult patient suffering from low back pain, having finished a FRP and possessing a smartphone, will be included. Investigators plan to include 150 patients in 6 centres. The duration of the inclusion period is 12 months; The duration of participation of each subject is 24 months. Inclusion will be on the last day of the FRP program. The Follow-up in consultation is scheduled at 3, 12 and 24 months with evaluation of usual criteria (physical, self-questionnaires, and advice on the practice of physical activities depending on what is achieved). In Pitie salpetriere center only, patients will have in addition: lumbar MRI at 3 and 12 months; central pain awareness assessment. The activity of patients in the MSP group will be recorded continuously par EMOTIV App; pain, mental health and days off every week and self-questionnaires at 1, 2 and 6 months. The primary analysis of all endpoints will be performed in the intent-to-treat population, i.e. all patients randomized to the study. The COMI score will be compared between the 2 randomized groups by a linear mixed model.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 18 or over
  • Disabling chronic low back pain: chronic painful patient, that is to say suffering from pain for more than 3 months, having interrupted all physical activity because of low back pain and have an indication for a FRP for low back pain.
  • Having reached the end of an FRP program
  • Possession of a smartphone
  • Fluency in French (writing, reading)
  • Health insurance coverage (beneficiary or beneficiary) except State Medical Aid.
  • Patient Informed Consent Signature

Exclusion criteria

  • Pregnant woman
  • Patient refusal
  • Patient deprived of liberty and patient under legal protection measure (guardianship, guardianship)
  • Patient participating to another interventional search

Treatment and study plan

Motivational Support Program Emotiv

Behavioral

A motivational support program including a motivational and self-assessment remote application in the form of a Smartphone application for chronic low back pain patients after multidisciplinary functional rehabilitation.

Primary outcomes

  1. Difference in disability and pain between the experimental (SHP) and control (usual care) groups, measured with the Core Outcome Measure Index (COMI) scale at 12 months.

    Time frame: 12 months after completion of the multidisciplinary functional rehabilitation program

    The Core Outcome Measure Index (COMI) was developed from requirements of international back pain experts. According to European experts, the COMI should currently be recommended in assessment of chronic low back pain. This questionnaire assesses pain and disability in low back pain. It includes 9 items and its score is between 0 and 10. Higher scores is the worse outcome.

Secondary outcomes

  1. Evolution of pain

    Time frame: At 3 months, 12 months and 24 months

    Pain will be measured by a Visual Analogic Scale (VAS) with a question about lumbar pain over the last 7 days. Minimum and maximum values are 0 and 100.

  2. Evolution of flexibility

    Time frame: At 3 months, 12 months and 24 months

    Flexibility will be evaluated by measuring the hand-to-ground distance

  3. Evolution of muscular endurance

    Time frame: At 3 months, 12 months and 24 months

    Muscular endurance will be assessed by measuring Shirado (abdominal endurance). Its score is between 0 and no limit. 0 is the worse outcome.

  4. Evolution of muscular endurance

    Time frame: At 3 months, 12 months and 24 months

    Muscular endurance will be assessed by measuring Sorensen (spinal extensor endurance). Its score is between 0 and no limit. 0 is the worse outcome.

  5. Evolution of disability and pain

    Time frame: At 3 months, 12 months and 24 months

    Disability and pain will be assessed by the Core Outcome Measure Index (COMI) questionnaire. Its score is between 0 and 10. Higher scores is the worse outcome.

  6. Evolution of endurance and sports performance (VO2 max)

    Time frame: At 3 months, 12 months and 24 months

    Endurance and sports performance will be assessed on the treadmill

  7. Evolution of the intensity of physical activity

    Time frame: At 3 months, 12 months and 24 months

    Intensity of physical activity will be assessed by the IPAQ (International Physical Activity Questionnaire). Scoring a high level of physical activity on the IPAQ means the physical activity levels equate to approximately one hour of activity per day or more at least a moderate intensity activity level.

  8. Evolution of muscular trophicity in the 2 groups

    Time frame: At 3 months and 12 months

    Muscular trophicity will be done by the measurement of the cross-sectional area (CSA) of the extensor muscles at the level of the upper and lower plateaus of L4 at the lumbar spine

  9. Evolution of the level of anxiety and depression

    Time frame: At 3 months, 12 months and 24 months

    Level of anxiety and depression will be assessed by the HAD (Hospital Anxiety and Depression) scale.

    14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D), thus allowing two scores (maximum and worse of each score equal 21)

  10. Evolution of the level of central pain awareness

    Time frame: At inclusion, 3 months, 12 months and 24 months

    Two parameters will be used, in accordance with international recommendations on Quantitative Sensory Testings : the pain pressure threshold using an algometer, at a distance from the painful area (forearm), and the temporal summation by repeating a painful stimulus with a calibrated needle (PinPrick)

  11. Medico-economic analysis

    Time frame: At 3 months, 12 months and 24 months

    The elements for the medico-economic analysis will be collected on the basis of a questionnaire validated in French. The data collected are : - consultations in general medicine and rheumatology as part of the usual follow-up of patients, - biological or imaging examinations carried out for the spinal problem, - medicinal treatments (drugs, infiltrative procedures) and non-medicinal treatments (physiotherapy, others) carried out for the spinal problem, - any hospitalizations related to the spinal problem

  12. Cost of care (i.e, health resource use and related costs or direct costs)

    Time frame: At 3 months, 12 months and 24 months

    Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued on the basis of the tariffs of the National Health Insurance Fund (CNAM). Health resource use related costs will be expressed in Euros

  13. Cost of care (i.e, health resource use and related costs or direct costs)

    Time frame: At 3 months, 12 months and 24 months

    Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the Common Classification of Medical Acts (CCAM). Health resource use related costs will be expressed in Euros

  14. Cost of care (i.e, health resource use and related costs or direct costs)

    Time frame: At 3 months, 12 months and 24 months

    Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the Nomenclature of Medical Biology Acts (NABM). Health resource use related costs will be expressed in Euros

  15. Cost of care (i.e, health resource use and related costs or direct costs)

    Time frame: At 3 months, 12 months and 24 months

    Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the national scale of costs (ENC) for hospitalisations. Health resource use related costs will be expressed in Euros

  16. Sick leave days

    Time frame: At 3 months, 12 months and 24 months

    The number of working days off work will be elicited

  17. Productivity loss (i.e, sick leave-related costs or indirect costs)

    Time frame: At 3 months, 12 months and 24 months

    Sick leave days will be valued on the basis of the average daily salaries published each year by the French National Institute of Statistics (INSEE, www.insee.fr). It will be expressed in Euros.

  18. Satisfaction with the program

    Time frame: At 3 months, 12 months and 24 months

    Satisfaction with the program will be measured by a Visual Analogic Scale (VAS). Minimum and maximum values are 0 and 100. The better score is 100.

  19. Adherence to the program

    Time frame: At 3 months, 12 months and 24 months

    Adherence to the program will be evaluated on the number of connection (minimum value 0 and no maximum)

  20. Adherence to the program

    Time frame: At 3 months, 12 months and 24 months

    Adherence to the program will be evaluated on the time of connection (minimum value 0 and no maximum)

  21. Adherence to the program

    Time frame: At 3 months, 12 months and 24 months

    Adherence to the program will be evaluated on number of reminders necessary by the coordinator in case of non connection and/or non attendance at the follow-up (minimum value 0 and non maximum)

Study contacts

Contact information is provided by the study sponsor or research team.

Bruno FAUTREL, Pr

CONTACT

[email protected]

01 42 17 78 01

Violaine FOLTZ, Dr

CONTACT

[email protected]

01 42 17 79 58

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Official study title

Evaluation of the Effectiveness of a MOTIVational Support Program After Multidisciplinary Functional Rehabilitation in Chronic Low Back Pain

Acronym: EMOTIV

Important dates

Study start
2023
Primary completion
2025
Study completion
2026
First posted
Mar 22, 2023
Registry last updated
Aug 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.